RPTX Latest Press Releases, Repare Therapeutics Inc. Corporate News

Releases

2.650

0.00%

0.000

All
Financials
Insiders

UPLOAD | Repare Therapeutics Inc.(0001808158)
09/17/2024 04:12
CORRESP | Repare Therapeutics Inc.(0001808158)
09/17/2024 04:12
8-K | Repare Therapeutics Inc.(0001808158)
08/28/2024 12:18
EFFECT | Repare Therapeutics Inc.(0001808158)
08/20/2024 02:03
8-K | Repare Therapeutics Inc.(0001808158)
08/07/2024 05:06
S-3 | Repare Therapeutics Inc.(0001808158)
08/06/2024 12:47
10-Q | Repare Therapeutics Inc.(0001808158)
08/06/2024 12:29
8-K | Repare Therapeutics Inc.(0001808158)
08/06/2024 12:21
4 | Repare Therapeutics Inc.(0001808158)
06/20/2024 12:37
4 | Repare Therapeutics Inc.(0001808158)
06/20/2024 12:36
4 | Repare Therapeutics Inc.(0001808158)
06/20/2024 12:36
4 | Repare Therapeutics Inc.(0001808158)
06/20/2024 12:36
4 | Repare Therapeutics Inc.(0001808158)
06/20/2024 12:36
4 | Repare Therapeutics Inc.(0001808158)
06/20/2024 12:35
4 | Repare Therapeutics Inc.(0001808158)
06/20/2024 12:35
4 | Repare Therapeutics Inc.(0001808158)
06/20/2024 12:35
3 | Repare Therapeutics Inc.(0001808158)
06/20/2024 12:28
8-K | Repare Therapeutics Inc.(0001808158)
06/17/2024 12:07
S-8 | Repare Therapeutics Inc.(0001808158)
05/24/2024 12:08
10-Q | Repare Therapeutics Inc.(0001808158)
05/07/2024 12:18
8-K | Repare Therapeutics Inc.(0001808158)
05/07/2024 12:15
8-K | Repare Therapeutics Inc.(0001808158)
04/26/2024 12:17
DEFA14A | Repare Therapeutics Inc.(0001808158)
04/26/2024 12:10
DEF 14A | Repare Therapeutics Inc.(0001808158)
04/26/2024 12:09
4 | Repare Therapeutics Inc.(0001808158)
04/01/2024 17:32
4 | Repare Therapeutics Inc.(0001808158)
04/01/2024 17:31
4 | Repare Therapeutics Inc.(0001808158)
04/01/2024 17:29
4 | Repare Therapeutics Inc.(0001808158)
04/01/2024 17:28
4 | Repare Therapeutics Inc.(0001808158)
03/27/2024 15:00
4 | Repare Therapeutics Inc.(0001808158)
03/27/2024 14:58
4 | Repare Therapeutics Inc.(0001808158)
03/27/2024 14:57
4 | Repare Therapeutics Inc.(0001808158)
03/27/2024 14:56
144 | Repare Therapeutics Inc.(0001808158)
03/27/2024 08:38
144 | Repare Therapeutics Inc.(0001808158)
03/26/2024 10:51
144 | Repare Therapeutics Inc.(0001808158)
03/25/2024 15:26
144 | Repare Therapeutics Inc.(0001808158)
03/25/2024 12:24
144 | Repare Therapeutics Inc.(0001808158)
03/25/2024 12:24
4 | Repare Therapeutics Inc.(0001808158)
03/05/2024 11:16
4 | Repare Therapeutics Inc.(0001808158)
03/04/2024 16:07
4 | Repare Therapeutics Inc.(0001808158)
03/04/2024 16:05
4 | Repare Therapeutics Inc.(0001808158)
03/04/2024 16:03
S-8 | Repare Therapeutics Inc.(0001808158)
02/28/2024 11:14
10-K | Repare Therapeutics Inc.(0001808158)
02/28/2024 02:18
8-K | Repare Therapeutics Inc.(0001808158)
02/28/2024 02:11
SC 13G | Repare Therapeutics Inc.(0001808158)
02/14/2024 16:03
SC 13G/A | Repare Therapeutics Inc.(0001808158)
02/14/2024 11:48
SC 13G/A | Repare Therapeutics Inc.(0001808158)
02/14/2024 03:55
8-K | Repare Therapeutics Inc.(0001808158)
02/12/2024 11:49
SC 13G/A | Repare Therapeutics Inc.(0001808158)
01/29/2024 11:02
8-K | Repare Therapeutics Inc.(0001808158)
01/25/2024 09:30

Webull provides the latest Repare Therapeutics Inc. (RPTX) stock and general news. This information may help you make smarter investment decisions.

About RPTX

Repare Therapeutics Inc. is a clinical-stage precision oncology company enabled by its proprietary synthetic lethality approach to the discovery and development of novel therapeutics. The Company utilizes its genome-wide, CRISPR-enabled SNIPRx platform to systematically discover and develop highly targeted cancer therapies focused on genomic instability, including DNA damage repair. Its pipeline includes RP-3467, a Phase 1 Polo ATPase inhibitor; RP-1664, a Phase 1 PLK4 inhibitor, and lunresertib, a PKMYT1 inhibitor.